The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.40
Bid: 1.30
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.20 (15.385%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.40
MAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options to Directors

11 Dec 2020 12:47

Marechale Capital Plc - Grant of Options to Directors

Marechale Capital Plc - Grant of Options to Directors

PR Newswire

London, December 11

Marechale Capital plc

(“Marechale” or the “Company”)

Grant of Options to Directors

Marechale Capital plc (AIM:MAC) announces that it has granted options in aggregate over 4,354,927 ordinary shares to Patrick Booth-Clibborn and Mark Warde-Norbury ("the Share Options") at 1.25p per share. The Share Options, which were approved by shareholders at the Company’s annual general meeting on 23 September 2019, were granted on 10 December 2020 and represent approximately 7.55% of the Company's current issued share capital.

The Share Options were awarded as follows:

Share Options Prior to GrantNumber of Share Options GrantedResultant Number of Share Options HeldAs a % of Current Issued Share Capital
Patrick Booth-Clibborn4,395,3034,037,6818,432,98414.62%
Mark Warde-Norbury547,971317,246865,2171.50%

Following the grant of the Share Options, the Company will have 9,846,172 options in issue representing 17.1% per cent of the issued share capital in aggregate.

The Share Options have been granted in accordance with rules of the Marechale Capital plc Enterprise Management Incentive Share Option Plan, which has been modified following shareholder approval to increase the total number of options that may be awarded. The Share Options granted have an exercise price or 1.25p and vest one-third per annum on the anniversary date of the grant. They are not subject to performance criteria and will expire on the fifth anniversary of the earliest date of exercise, the latter taken to be the date on which the options have vested.

The grant of Share Options to the Directors described above, is a related party transaction for the purposes of Rule 13 of the AIM Rules. With the exception of Patrick Booth-Clibborn and Mark Warde-Norbury, the directors consider, having consulted with the Company's Nominated Adviser Cairn Financial Advisers LLP, that the terms of the transaction are fair and reasonable insofar as shareholders are concerned.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information please contact:

Marechale Capital plc Mark Warde-Norbury / Patrick Booth-ClibbornTel: +44 (0)20 7628 5582
Cairn Financial Advisers LLP (Nomad) Jo Turner / Sandy Jamieson / Mark RogersTel: +44 (0)20 7213 0880
Novum Securities Limited (Broker) Colin RowburyTel: +44 (0)20 7399 9427

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1Details of the person discharging managerial responsibilities/person closely associated
a.NamePatrick Booth-Clibborn Mark Warde-Norbury
2Reason for notification
a.Position/StatusChief Executive Executive Chairman
b.Initial notification/ AmendmentInitial
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.NameMarechale Capital plc
b.LEI213800WAVVOPS85N2205
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.Description of the financial instrument, type of instrument Identification CodeOrdinary Shares ISIN: GB0005401087
b.Nature of the transactionGrant of share options at an exercise price of 1.25 pence
c.Price(s) and volume(s)
Volume(s)Exercise Price (p)
4,037,6811.25p
b) 317,2461.25p
d.Aggregated information - Aggregated Volume - Price 4,354,927 1.25 pence
e.Date of the transaction10/12/2020
f.Place of the transactionLondon Stock Exchange, AIM
Date   Source Headline
5th Dec 20237:00 amPRNHalf-year Report
22nd Nov 20231:00 pmPRNDirectorate Change
13th Oct 20233:51 pmPRNResult of AGM
19th Sep 20233:40 pmPRNNotice of AGM and Posting of Accounts
22nd Aug 20237:00 amPRNFinancial Statements for the Year Ended 30 April 2023
3rd Aug 202312:00 pmPRNHolding(s) in Company
28th Jun 20237:00 amPRNSubscription and Issue of Equity
2nd Mar 20227:00 amPRNPlacing, Subscription and Issue of Equity
1st Dec 20217:00 amPRNHalf-year Report
14th Oct 20213:28 pmRNSResult of AGM
11th Oct 20213:08 pmPRNHolding(s) in Company
8th Oct 20213:29 pmPRNHolding(s) in Company
5th Oct 20217:00 amPRNSubscription and Issue of Equity
22nd Sep 20212:57 pmPRNNotice of AGM
8th Sep 202111:54 amPRNHolding(s) in Company
7th Sep 20212:11 pmPRNDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSFinal Results
12th Mar 20219:32 amPRNHolding(s) in Company
5th Mar 20211:29 pmPRNHolding(s) in Company
5th Mar 20218:50 amPRNHolding(s) in Company
4th Mar 20213:24 pmPRNTrading Update
4th Mar 20219:19 amPRNHolding(s) in Company
23rd Feb 20215:00 pmPRNHolding(s) in Company
23rd Feb 20217:00 amPRNDirector/PDMR Shareholding
10th Feb 20212:27 pmPRNHolding(s) in Company
10th Feb 20217:00 amPRNHolding(s) in Company
4th Feb 20219:15 amPRNExercise of Options and Issue of Equity
3rd Feb 20217:00 amPRNStatement re Share Price Movement
2nd Feb 20216:20 pmPRNHolding(s) in Company
26th Jan 202111:47 amPRNPlacing, Subscription and Issue of Equity
11th Dec 202012:47 pmPRNGrant of Options to Directors
24th Nov 20207:00 amPRNHalf-year Report
26th Oct 20201:16 pmPRNResult of AGM
2nd Oct 20207:00 amRNSChange of Adviser
28th Sep 20201:20 pmRNSPosting of Annual Report and Notice of AGM
25th Aug 202010:39 amRNSHolding(s) in Company
24th Aug 20207:00 amRNSFinal Results
10th Aug 202010:03 amRNSHolding(s) in Company
7th Aug 20201:05 pmRNSHolding(s) in Company
6th Aug 202010:09 amRNSHolding(s) in Company
5th Aug 202011:35 amRNSHolding(s) in Company
4th Aug 20201:03 pmRNSHolding(s) in Company
30th Jul 20204:40 pmRNSSecond Price Monitoring Extn
30th Jul 20204:35 pmRNSPrice Monitoring Extension
17th Jan 20203:31 pmRNSHolding(s) in Company
12th Dec 20193:08 pmRNSHalf-year Report
24th Sep 201912:16 pmRNSHolding(s) in Company
23rd Sep 20193:38 pmRNSResult of AGM
2nd Sep 20192:46 pmRNSPosting of Annual Report and Notice of AGM
29th Aug 20193:48 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.